Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDeferred TaxesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Net Income (2016 - 2025)

Historic Net Income for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$3.3 billion.

  • Sanofi's Net Income fell 165531.31% to -$3.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year increase of 437241.82%. This contributed to the annual value of $3.2 billion for FY2025, which is 478879.8% up from last year.
  • As of Q4 2025, Sanofi's Net Income stood at -$3.3 billion, which was down 165531.31% from $3.3 billion recorded in Q3 2025.
  • Sanofi's Net Income's 5-year high stood at $12.2 billion during Q4 2022, with a 5-year trough of -$3.3 billion in Q4 2025.
  • For the 5-year period, Sanofi's Net Income averaged around $2.2 billion, with its median value being $2.4 billion (2021).
  • Over the last 5 years, Sanofi's Net Income had its largest YoY gain of 751383.86% in 2025, and its largest YoY loss of 165531.31% in 2025.
  • Sanofi's Net Income (Quarter) stood at $289.9 million in 2021, then soared by 4125.54% to $12.2 billion in 2022, then crashed by 103.86% to -$472.3 million in 2023, then soared by 59.73% to -$190.2 million in 2024, then plummeted by 1655.31% to -$3.3 billion in 2025.
  • Its Net Income stands at -$3.3 billion for Q4 2025, versus $3.3 billion for Q3 2025 and $3.1 billion for Q2 2025.